文献速递产科

门诊球囊导管与住院前列腺素引产的随机试验

Outpatient balloon catheter vs inpatient prostaglandin for induction of labor: a randomized trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-04-06

该优势随机对照试验在新西兰11家公立产科医院纳入足月、单胎头位、修改Bishop评分0至6分的孕妇,比较门诊球囊导管引产与住院阴道前列腺素E2引产。门诊球囊组剖宫产率41.0%,住院前列腺素组35.2%(调整比值比1.27;95%置信区间0.98-1.65)。门诊球囊引产未降低剖宫产率,且未增加母婴不良事件。

要点

  • 门诊球囊组剖宫产率41.0%,住院前列腺素组35.2%(调整比值比1.27;95%置信区间0.98-1.65)。
  • 门诊球囊组更常行人工破膜、使用缩宫素和硬膜外镇痛。
  • 母婴不良事件发生率两组无差异,门诊球囊引产可常规提供。

核心结论

  • 门诊球囊导管引产与住院阴道前列腺素E2引产相比未降低剖宫产率。
  • 门诊使用球囊导管似乎不增加母婴不良事件发生率,可常规提供。

研究设计与样本

  • 优势随机对照试验,纳入新西兰11家公立产科医院的孕妇。
  • 纳入标准为足月、单胎头位、有任合并症、修改Bishop评分0至6分的初产妇和经产妇。
  • 门诊单球囊导管引产组539例,住院阴道前列腺素E2引产组548例。
  • 采用中央安全在线随机化网站按1:1比例随机,按产次和医院分层,参与者和结局评估者未设盲。
  • 采用意向性分析并校正分层变量。

主要发现

  • 门诊球囊组剖宫产率41.0%,住院前列腺素组35.2%(调整比值比1.27;95%置信区间0.98-1.65)。
  • 门诊球囊组更常行人工破膜、使用缩宫素和硬膜外镇痛。
  • 母婴不良事件发生率两组无差异。

临床怎么用

  • 门诊球囊导管引产可常规提供,似乎不增加母婴不良事件发生率。

局限性

  • 参与者和结局评估者未设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Approximately 1 in 4 pregnant women undergo induction of labor. Meta-analyses have shown that mechanical methods of induction of labor are safe and effective, as is starting induction in an outpatient setting. However, few studies have evaluated outpatient balloon catheter induction in comparison with pharmacologic methods. OBJECTIVE: This study aimed to determine whether women who underwent outpatient induction of labor with a balloon catheter would have a lower cesarean delivery rate than women who underwent inpatient induction of labor with vaginal prostaglandin E2 without an increase in adverse maternal or neonatal events. STUDY DESIGN: This was a superiority randomized controlled trial. The eligibility criteria were pregnant women (nullipara and multipara) with a live singleton fetus in vertex presentation with any medical comorbidity who underwent planned induction of labor at term and who had an initial modified Bishop Score of 0 to 6 at 1 of 11 public maternity hospitals in New Zealand. The intervention groups were outpatient single balloon catheter induction in comparison with inpatient vaginal prostaglandin E2 induction. The primary hypothesis was that participants who started their induction at home with a balloon catheter would have a lower risk for cesarean delivery than participants who started their induction with prostaglandins and remained in hospital throughout. The primary outcome was cesarean delivery rate. Participants were randomized using a centralized secure online randomization website in a 1:1 ratio, stratified by parity and hospital. The participants and outcome assessors were not blinded to group allocation. An intention-to-treat analysis with adjustment for stratification variables was used. RESULTS: A total of 539 participants were randomized to outpatient balloon catheter induction, and 548 participants were randomized to inpatient prostaglandin induction; the mode of birth was reported for all participants. The cesarean delivery rate was 41.0% among participants allocated to outpatient balloon induction and 35.2% among those allocated to inpatient prostaglandin induction (adjusted odds ratio, 1.27; 95% confidence interval, 0.98-1.65). Women in the outpatient balloon catheter group were more likely to have artificial rupture of membranes and to received oxytocin and an epidural. No differences were found in the rates of adverse maternal or neonatal events. CONCLUSION: Outpatient balloon catheter induction was not found to reduce the cesarean delivery rate when compared with inpatient vaginal prostaglandin E2 induction. The use of balloon catheters in an outpatient setting does not seem to increase the rate of adverse events for mothers or babies and can be offered routinely.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Wise MR, Thompson JMD, Battin M, et al. Outpatient balloon catheter vs inpatient prostaglandin for induction of labor: a randomized trial. Am J Obstet Gynecol MFM. 2023. PMID: 37028554. doi:10.1016/j.ajogmf.2023.100958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。